Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Thromboembolism 1Spinal Stenosis 1Pulmonary Embolism 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Burkitt Lymphoma 1Brain Neoplasms 1

Interventions

Rivaroxaban 2bemiparin 1apixaban 1Warfarin 1Tinzaparin 1Phenprocoumon 1Nephrectomy 1Nadroparin 1Heparin 1Fondaparinux 1Enoxaparin 1Drug Delivery Systems 1Dalteparin 1Dabigatran 1Aspirin 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pulmonary Embolism × Heparin × Clear all
NCT01727427 2019-08-08

Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients

G. d'Annunzio University

Completed
695 enrolled

Neoplasms, Pulmonary Embolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡